A Clinical Study for Developing Artificial Intelligence(AI)-Based Clustering Model for Personalized Medicine in Acute Respiratory Failure

Launched by SAMSUNG MEDICAL CENTER · Jun 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how to use artificial intelligence (AI) to better understand and personalize treatment for patients experiencing acute respiratory failure. Acute respiratory failure is a serious condition where the lungs can't provide enough oxygen to the body, often requiring patients to use special breathing support like high flow nasal cannulas or ventilators. The researchers want to collect and analyze information from patients in the intensive care unit (ICU) who are facing this condition, as well as from a control group of patients who do not have acute respiratory failure, to identify different patterns that could help improve care.

To be eligible for this study, participants must be at least 18 years old and either require breathing support due to acute respiratory failure or be part of the control group where patients do not need such support. Participants will be asked to provide clinical information, and there are some exclusions, such as those who have already received certain treatments for more than 48 hours or have been transferred from another hospital. If you join the study, you can expect to have your health information collected and analyzed in hopes of finding better ways to treat this serious condition.

Gender

ALL

Eligibility criteria

• # Inclusion Criteria:
• • - Acute Respiratory Failure group
• Among patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital, if all of the following conditions are met:
• • 1) Age 18 or older 2) Patients who require treatment with high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) due to acute respiratory failure.
• • - control group For comparative analysis, among patients admitted to the internal medicine intensive care unit at Samsung Seoul Hospital who meet all of the following conditions, they are registered as a control group with the consent of the subjects and undergo the same research procedure.
• • 1. Age 18 or older
• • 2. Patients who do not require high flow nasal cannula (HFNC), non-invasive ventilation (NIV (BIPAP or CPAP)), or mechanical ventilation (MV) treatment
• * Exclusion Criteria:
• • If any of the following criteria applies, you will not be permitted to participate in this clinical trial.
• • 1. Patients 48 hours after oxygen treatment (HFNC, NIV (BIPAP or CPAP), MV)
• • 2. Patients transferred from another hospital
• • 3. Patients with limitations in treatment